Home Stock

Stock Research: Cipla

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Cipla

NSEI:CIPLA INE059A01026
82
  • Value
    72
  • Growth
    52
  • Safety
    Safety
    96
  • Combined
    94
  • Sentiment
    46
  • 360° View
    360° View
    82
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Cipla Limited is a global pharmaceutical company that develops, manufactures, and markets a wide range of branded and generic formulations and APIs. The company operates in the pharmaceuticals and new ventures segments. Its product portfolio includes complex generics and drugs in respiratory, anti-retroviral, urology, cardiology, anti-infective, and central nervous system (CNS) areas. Its main geographical segments include India, the United States, South Africa, and the Rest of the World. In the last fiscal year, the company had a market cap of $13,867 million, profits of $2,035 million, and revenue of $3,224 million with 30313 employees.

more
Strongest Rank Profit Growth
Weakest Rank Safety
Country India
Industry Pharmaceuticals
Size Large
Website cipla.com
Index
Low Emissions
Good Governace Growth Markets
Human Rights
Low Waste
Recycling
CNX Nifty 50
Cipla stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 8-Jan-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
72 61 61 65
Growth
52 53 51 53
Safety
Safety
96 89 77 57
Sentiment
46 89 47 98
360° View
360° View
82 95 76 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
37 54 59 74
Opinions Change
52 95 50 69
Pro Holdings
n/a 80 67 80
Market Pulse
76 78 21 73
Sentiment
46 89 47 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
72 61 61 65
Growth
52 53 51 53
Safety Safety
96 89 77 57
Combined
94 89 79 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
56 48 50 65
Price vs. Earnings (P/E)
66 60 64 65
Price vs. Book (P/B)
62 52 60 64
Dividend Yield
53 48 34 34
Value
72 61 61 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
43 37 34 23
Profit Growth
17 49 73 58
Capital Growth
70 45 57 75
Stock Returns
71 61 49 45
Growth
52 53 51 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
86 82 74 54
Refinancing
81 62 72 78
Liquidity
85 68 60 39
Safety Safety
96 89 77 57

Similar Stocks

Discover high‑ranked alternatives to Cipla and broaden your portfolio horizons.

Bosch

BSE:500530
Country: India
Industry: Auto Parts & Equipment
Size: Medium
Full Stock Analysis

Kalbe Farma

IDX:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Fleury

BOVESPA:FLRY3
Country: Brazil
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Maruti Suzuki

NSEI:MARUTI
Country: India
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This stock has excellent financial qualities (value, growth, and safety are high) but a negative professional market sentiment. It suits an investor who believes the negative sentiment is a temporary overreaction and is looking for a financially solid company.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews